LGI1 antibody encephalitis: acute treatment comparisons and outcome
Andrew Rodriguez(The University of Texas MD Anderson Cancer Center), Eoin P. Flanagan(Mayo Clinic in Arizona), Eva Alden(Mayo Clinic), Nicholas L. Zalewski(Mayo Clinic in Arizona), Divyanshu Dubey(Mayo Clinic in Arizona), A. Sebastian López‐Chiriboga, Avi Gadoth(Tel Aviv University), David B. Burkholder(Mayo Clinic), Andrew McKeon(Mayo Clinic), Michael R. Basso(Mayo Clinic), Jeffrey W. Britton(Mayo Clinic in Arizona), Gregory S. Day(Jacksonville College), Shehroo B. Pudumjee(Mayo Clinic), Bradley F. Boeve(Mayo Clinic in Arizona), Christopher J. Klein(Mayo Clinic), Elia Sechi(Mayo Clinic), Michel Toledano, Sean J. Pittock(Mayo Clinic), Αναστασία Ζεκερίδου(Mayo Clinic)
Cited by 130
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k
The spectrum of neuromyelitis optica
|The Lancet Neurology|2007|2.2k